Rat models were genetically modified to simulate advanced aging, and AD showed improvements in memory rescue with the administration of vafidemstat in conjunction with the selective monoamine oxidase type B (MAO-B) inhibitor rasagiline. Here, MAOB is linked to Alzheimer disease.